Eye Drops and Lubricants Market by Type (Antibiotics, Hormones, Artificial Tears, and Others) and Application (Eye Diseases, Eye Care, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3458
- Pages: 187
-
Format:
The global eye drops and lubricants market generated $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025.
Eye drops and lubricants are used to relieve people suffering from various eye problems, such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the eye drops and lubricants market in near future.
Rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases are the factors that drive the growth of the global eye drops and lubricants market. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth. On the contrary, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion.
The global eye drops market is segmented based on type, application, and region. By type, the market is categorized into antibiotics, hormones, artificial tears, and others. Based on application, the market is divided into eye diseases, eye care, and others. The eye diseases segment is further classified into dry eye, glaucoma, conjunctivitis, refractive errors, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global eye drops and lubricants market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Type
o Antibiotics
o Hormones
o Artificial Tears
o Others
By Application
o Eye Diseases
Dry Eye
Glaucoma
Conjunctivitis
Refractive Errors
Others
o Eye Care
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Akorn Consumer Health (TheraTears)
Allergan Plc
Johnson & Johnson
Novartis International AG (Alcon Inc.)
Pfizer Inc.
Prestige Consumer Healthcare, Inc.
Sager Pharma Kft.
ROHTO Pharmaceutical Co., Ltd.
Similasan Corporation USA
Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
The other players in the value chain include (profiles not included in the report):
Jawa Pharmaceuticals Pvt. Ltd.
Maya Biotech
Neiss Labs Ltd.
Hanuchem Laboratories
Oculent Healthcare
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Top player positioning, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in prevalence of ophthalmic disorders worldwide
3.5.1.2. Change in the demographics across the globe
3.5.1.3. Drug discovery and development
3.5.2. Restraints
3.5.2.1. Longer timelines required for the development of eye drops and lubricants
3.5.2.2. Risk of side effects associated with eye drops and lubricants
3.5.3. Opportunity
3.5.3.1. Increase in investment by market players in the emerging economies
Chapter: 4: EYE DROPS AND LUBRICANTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Antibiotics
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Hormones
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Artificial tears
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
Chapter: 5: GLOBAL EYE-DROP AND LUBRICANTS MARKET BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Eye diseases
5.2.1. Market size and forecast, by type
5.2.1.1. Dry Eye
5.2.1.1.1. Market size and forecast
5.2.1.2. Glaucoma
5.2.1.2.1. Market size and forecast
5.2.1.3. Conjunctivitis
5.2.1.3.1. Market size and forecast
5.2.1.4. Refractive Errors
5.2.1.4.1. Market size and forecast
5.2.1.5. Others
5.2.1.5.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Eye care
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country
Chapter: 6: EYE DROPS AND LUBRICANT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America eye drops and lubricant market, by type
6.2.3. North America eye drops and lubricant market, by application
6.2.4. North America eye drops and lubricant market, by country
6.2.4.1. U.S. eye drops and lubricant market, by type
6.2.4.2. U.S. eye drops and lubricant market, by application
6.2.4.3. Canada eye drops and lubricant market, by type
6.2.4.4. Canada eye drops and lubricant market, by application
6.2.4.5. Mexico eye drops and lubricant market, by type
6.2.4.6. Mexico eye drops and lubricant market, by application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe eye drops and lubricant market, by type
6.3.3. Europe eye drops and lubricant market, by application
6.3.4. Europe eye drops and lubricant market, by country
6.3.4.1. Germany eye drops and lubricant market, by type
6.3.4.2. Germany eye drops and lubricant market, by application
6.3.4.3. France eye drops and lubricant market, by type
6.3.4.4. France eye drops and lubricant market, by application
6.3.4.5. UK eye drops and lubricant market, by type
6.3.4.6. UK eye drops and lubricant market, by application
6.3.4.7. Italy eye drops and lubricant market, by type
6.3.4.8. Italy eye drops and lubricant market, by application
6.3.4.9. Spain eye drops and lubricant market, by type
6.3.4.10. Spain eye drops and lubricant market, by application
6.3.4.11. Rest of Europe eye drops and lubricant market, by type
6.3.4.12. Rest of Europe eye drops and lubricant market, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific eye drops and lubricant market, by type
6.4.3. Asia-Pacific eye drops and lubricant market, by application
6.4.4. Asia-Pacific eye drops and lubricant market, by country
6.4.4.1. Japan eye drops and lubricant market, by type
6.4.4.2. Japan eye drops and lubricant market, by application
6.4.4.3. China eye drops and lubricant market, by type
6.4.4.4. China eye drops and lubricant market, by application
6.4.4.5. India eye drops and lubricant market, by type
6.4.4.6. India eye drops and lubricant market, by application
6.4.4.7. Australia eye drops and lubricant market, by type
6.4.4.8. Australia eye drops and lubricant market, by application
6.4.4.9. South Korea eye drops and lubricant market, by type
6.4.4.10. South Korea eye drops and lubricant market, by application
6.4.4.11. Rest of Asia-Pacific eye drops and lubricant market, by type
6.4.4.12. Rest of Asia-Pacific eye drops and lubricant market, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA eye drops and lubricant market, by type
6.5.3. LAMEA eye drops and lubricant market, by application
6.5.4. LAMEA eye drops and lubricant market, by country
6.5.4.1. Brazil eye drops and lubricant market, by type
6.5.4.2. Brazil eye drops and lubricant market, by application
6.5.4.3. Saudi Arabia eye drops and lubricant market, by type
6.5.4.4. Saudi Arabia eye drops and lubricant market, by application
6.5.4.5. Rest of LAMEA eye drops and lubricant market, by type
6.5.4.6. Rest of LAMEA eye drops and lubricant market, by application
Chapter: 7: COMPANY PROFILES
7.1. AKORN CONSUMER HEALTH (THERATEARS)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.2. ALLERGAN PLC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. JOHNSON & JOHNSON
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. NOVARTIS INTERNATIONAL AG (ALCON INC.)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. PFIZER INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. PRESTIGE CONSUMER HEALTHCARE, INC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.7. SAGER PHARMA KFT.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.8. ROHTO PHARMACEUTICAL CO., LTD.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. SIMILASAN CORPORATION USA
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (BAUSCH & LOMB INCORPORATED)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
